13
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Analysis of peptides derived from Pro Atrial Natriuretic Peptide that circulate in man and increase in heart disease

, , , &
Pages 205-216 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. H. Henriksen, V. Gülberg, A. L. Gerbes, F. Bendtsen & S. Møller. (2003) Increased Arterial Compliance in Cirrhosis is Related to Decreased Arterial C-type Natriuretic Peptide, but not to Atrial Natriuretic Peptide. Scandinavian Journal of Gastroenterology 38:5, pages 559-564.
Read now

Articles from other publishers (25)

Chiaki Nagai‐Okatani, Kenji Kangawa & Naoto Minamino. (2017) Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization. Journal of Peptide Science 23:7-8, pages 486-495.
Crossref
David L Vesely. (2013) Cardiac hormones for the treatment of cancer. Endocrine-Related Cancer 20:3, pages R113-R125.
Crossref
David L. Vesely. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney 1241 1281 .
David L. Vesely. (2023) Cardiac and Renal Hormones. Journal of Investigative Medicine 57:1, pages 22-28.
Crossref
David L. Vesely. 2008. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney 947 977 .
David L. Vesely. (2008) Urodilatin: A better natriuretic peptide?. Current Heart Failure Reports 4:3, pages 147-152.
Crossref
Brian A. Vesely, Ehrentraud J. Eichelbaum, Abdel A. Alli, Ying Sun, William R. GowerJr.Jr. & David L. Vesely. (2007) Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide. Cancer Letters 254:1, pages 94-101.
Crossref
Olga V. FedorovaNatalia I. AgalakovaChristopher H. MorrellEdward G. LakattaAlexei Y. Bagrov. (2006) ANP Differentially Modulates Marinobufagenin-Induced Sodium Pump Inhibition in Kidney and Aorta. Hypertension 48:6, pages 1160-1168.
Crossref
Ehrentraud J. Eichelbaum, Brian A. Vesely, Abdel A. Alli, Ying Sun, William R. GowerJr.Jr. & David L. Vesely. (2006) Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours. Endocrine 30:3, pages 325-332.
Crossref
B. A. Vesely, E. J. Eichelbaum, A. A. Alli, Y. Sun, W. R. GowerJrJr & D. L. Vesely. (2006) Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers. European Journal of Clinical Investigation 36:11, pages 810-819.
Crossref
David L Vesely. (2006) WHICH OF THE CARDIAC NATRIURETIC PEPTIDES IS MOST EFFECTIVE FOR THE TREATMENT OF CONGESTIVE HEART FAILURE, RENAL FAILURE AND CANCER?. Clinical and Experimental Pharmacology and Physiology 33:3, pages 169-176.
Crossref
Brian A. Vesely, Shannon R. Fitz, William R. GowerJr.Jr. & David L. Vesely. (2006) Vessel dilator: Most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells. Cancer Letters 233:2, pages 226-231.
Crossref
David L. Vesely. (2023) Atrial Natriuretic Peptides: Anticancer Agents. Journal of Investigative Medicine 53:7, pages 360-365.
Crossref
B. A. Vesely, A. A. Alli, S. J. Song, W. R. GowerJr.Jr., J. Sanchez‐Ramos & D. L. Vesely. (2005) Four peptide hormones’ specific decrease (up to 97%) of human prostate carcinoma cells. European Journal of Clinical Investigation 35:11, pages 700-710.
Crossref
B. A. Vesely, S. Song, J. Sanchez‐Ramos, S. R. Fitz, A. A. Alli, S. M. Solivan, W. R. GowerJrJr & D. L. Vesely. (2005) Five cardiac hormones decrease the number of human small‐cell lung cancer cells. European Journal of Clinical Investigation 35:6, pages 388-398.
Crossref
B. A. Vesely, S. Song, J. Sanchez‐Ramos, S. R. Fitz, S. M. Solivan, W. R. GowerJrJr & D. L. Vesely. (2005) Four peptide hormones decrease the number of human breast adenocarcinoma cells. European Journal of Clinical Investigation 35:1, pages 60-69.
Crossref
D. L. Vesely, L. C. Clark, A. H. Garces, Q. W. McAfee, J. Soto & W. R. GowerJrJr. (2004) Novel therapeutic approach for cancer using four cardiovascular hormones. European Journal of Clinical Investigation 34:10, pages 674-682.
Crossref
Hamang Patel, John R. Dietz, Ashley Owen, Gloria San Miguel, Michael T. Mccormick, Douglas D. Schocken & David L. Vesely. (2016) Combined Treatment with Vessel Dilator and Kaliuretic Hormone in Persons with Congestive Heart Failure. Experimental Biology and Medicine 229:6, pages 521-527.
Crossref
B. A. Vesely, Q. McAfee, W. R. GowerJrJr & D. L. Vesely. (2003) Four peptides decrease the number of human pancreatic adenocarcinoma cells. European Journal of Clinical Investigation 33:11, pages 998-1005.
Crossref
David L. Vesely. (2003) Natriuretic peptides and acute renal failure. American Journal of Physiology-Renal Physiology 285:2, pages F167-F177.
Crossref
Alexander W. Biondo, Zonglin L. Liu, Charles E. Wiedmeyer, Helio S. Autran de Morais, David D. Sisson & Philip F. Solter. (2002) Genomic sequence and cardiac expression of atrial natriuretic peptide in cats. American Journal of Veterinary Research 63:2, pages 236-240.
Crossref
David L. Vesely, Gloria I. San Miguel, Imran Hassan, William R. GowerJr.Jr. & Douglas D. Schocken. (2001) Atrial Natriuretic Hormone, Vessel Dilator, Long-Acting Natriuretic Hormone, and Kaliuretic Hormone Decrease the Circulating Concentrations of Total and Free T4 and Free T3 with Reciprocal Increase in TSH. The Journal of Clinical Endocrinology & Metabolism 86:11, pages 5438-5442.
Crossref
Aldo Clerico, Silvia Del Ry & Daniela Giannessi. (2000) Measurement of Cardiac Natriuretic Hormones (Atrial Natriuretic Peptide, Brain Natriuretic Peptide, and Related Peptides) in Clinical Practice: The Need for a New Generation of Immunoassay Methods. Clinical Chemistry 46:10, pages 1529-1534.
Crossref
Elio F De Palo, Wolfgang Woloszczuk, Martina Meneghetti, Carlo B De Palo, Henning B Nielsen & Niels H Secher. (2000) Circulating Immunoreactive proANP(1-30) and proANP(31-67) in Sedentary Subjects and Athletes. Clinical Chemistry 46:6, pages 843-847.
Crossref
Engelbert Hartter, Shiva Khalafpour, Albert Mißbichler, Gerhard Hawa & Wolfgang Woloszczuk. (2000) Enzyme Immunoassays for Fragments (Epitopes) of Human Proatrial Natriuretic Peptides. cclm 38:1, pages 27-32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.